Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Secugen is a Spanish biotechnology company specializing in molecular genetics and DNA sequencing services, now operating as part of the ARQUIMEA group. Founded as a spin-off from the Spanish National Research Council (CSIC), the company provides a comprehensive suite of genomic services, including Sanger sequencing, Next-Generation Sequencing (NGS), and fragment analysis. Secugen also offers specialized genetic diagnostic services for hereditary diseases and rare conditions, catering to clinical, academic, and pharmaceutical sectors. With over three decades of experience, the company is a leading provider of molecular biology solutions in Spain. Their facilities are located within the Centro de Investigaciones Biológicas (CIB-CSIC) in Madrid, facilitating close collaboration with top-tier research institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SecuGen.